Keynote Financial Services Llc
Source: SEC Form 13F · as of Mar 2026Keynote Financial Services Llc holds 17 biotech & pharma companies tracked by BioSniper, totaling $29.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$29.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for AbbVie Inc. (ABBV)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 39,267 | $8.5M |
| JNJJOHNSON & JOHNSON | 12,332 | $3.0M |
| PFEPFIZER INC | 95,399 | $2.7M |
| ABTABBOTT LABORATORIES | 25,058 | $2.6M |
| AMGNAMGEN INC | 6,389 | $2.2M |
| BMYBRISTOL MYERS SQUIBB CO | 32,025 | $1.9M |
| MRKMerck & Co., Inc. | 14,604 | $1.8M |
| LLYELI LILLY & Co | 1,904 | $1.8M |
| GILDGILEAD SCIENCES, INC. | 11,902 | $1.7M |
| PMPhilip Morris International Inc | 6,539 | $1.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,138 | $879K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,231 | $550K |
| ZBHZimmer Biomet Holdings Inc. | 4,897 | $443K |
| CAHCardinal Health Inc. | 1,389 | $294K |
| ELVElevance Health Inc. | 705 | $206K |
| VTRSViatris Inc | 12,440 | $168K |
| CELUCelularity Inc. | 29,320 | $39K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.